Akorn, Inc. (NASDAQ:AKRX) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders.
Akorn, Inc. (the Company) held a special meeting of the
shareholders on December 16, 2016 at the Companys corporate
headquarters. The voting results on the proposals considered at
the special meeting are provided below.
Proposal 1: The Akorn, Inc. 2016 Employee Stock Purchase Plan was
approved with the voting results as follows:
| For | Against | Abstentions | Broker Non-Votes |
| 106,525,154 | 241,303 | 213,525 |
Proposal 2: The amendment and restatement of the Akorn, Inc. 2014
Stock Option Plan was approved with the voting results as
follows:
| For | Against | Abstentions | Broker Non-Votes |
| 99,085,942 | 7,855,783 | 38,257 |
About Akorn, Inc. (NASDAQ:AKRX)
Akorn Inc., together with its subsidiaries, is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment is engaged in manufacturing and marketing generic and branded prescription pharmaceuticals, including ophthalmics, injectables, oral liquids, otics, topical, inhalants and nasal sprays. The Consumer Health segment is engaged in manufacturing and marketing branded and private-label animal health and OTC products. The Company’s Akorn Consumer Health division (ACH) markets a portfolio of OTC brands and various formulations of private-label OTC pharmaceutical products. Its OTC brand is TheraTears Therapy for Your Eyes, which is a family of therapeutic eye care products. Akorn, Inc. (NASDAQ:AKRX) Recent Trading Information
Akorn, Inc. (NASDAQ:AKRX) closed its last trading session up +0.13 at 21.05 with 1,864,280 shares trading hands.
